|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
21,110,000 |
Market
Cap: |
5.48(M) |
Last
Volume: |
4,769,812 |
Avg
Vol: |
4,756,851 |
52
Week Range: |
$0.2598 - $0.2598 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Plus Therapeutics is a clinical-stage pharmaceutical company focused on the development, manufacture and commercialization of treatments for patients battling cancer and other life-threatening diseases. The clinical stage drugs in Co.'s pipeline are: Rhenium NanoLiposomes, a radiotherapy for patients with recurrent glioblastoma; DocePLUS, a chemotherapy for patients with tumors that has been evaluated in a completed U.S. single-center Phase 1 clinical trial; and DoxoPLUS, a generic chemotherapy that has been evaluated in a completed, bioequivalence clinical trial in the U.S., Canada, and Ukraine versus Janssen's CAELYX® in patients with ovarian cancer.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
48,285 |
48,285 |
100,872 |
108,373 |
Total Buy Value |
$98,501 |
$98,501 |
$185,764 |
$199,106 |
Total People Bought |
6 |
6 |
6 |
6 |
Total Buy Transactions |
6 |
6 |
17 |
20 |
Total Shares Sold |
0 |
0 |
2,068 |
3,568 |
Total Sell Value |
$0 |
$0 |
$4,053 |
$4,525 |
Total People Sold |
0 |
0 |
1 |
2 |
Total Sell Transactions |
0 |
0 |
1 |
2 |
End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Calhoun Christopher J |
Chief Executive Officer |
|
2006-07-05 |
4 |
AS |
$7.50 |
$450 |
D/D |
(60) |
150,000 |
|
- |
|
Calhoun Christopher J |
Chief Executive Officer |
|
2006-07-05 |
4 |
OE |
$0.15 |
$9 |
D/D |
60 |
150,060 |
|
- |
|
Cox Marshall G |
Director |
|
2006-05-26 |
4 |
S |
$8.00 |
$11,200 |
I/I |
(1,400) |
3,934 |
|
- |
|
Calhoun Christopher J |
Chief Executive Officer |
|
2006-05-11 |
4 |
S |
$8.09 |
$671 |
D/D |
(83) |
150,000 |
|
- |
|
Calhoun Christopher J |
Chief Executive Officer |
|
2006-05-11 |
4 |
OE |
$0.15 |
$12 |
D/D |
83 |
150,083 |
|
- |
|
Calhoun Christopher J |
Chief Executive Officer |
|
2006-05-10 |
4 |
AS |
$8.06 |
$95,729 |
D/D |
(11,877) |
150,000 |
|
- |
|
Calhoun Christopher J |
Chief Executive Officer |
|
2006-05-10 |
4 |
OE |
$0.15 |
$1,782 |
D/D |
11,877 |
161,877 |
|
- |
|
Calhoun Christopher J |
Chief Executive Officer |
|
2006-05-08 |
4 |
S |
$8.06 |
$22,568 |
D/D |
(2,800) |
50,000 |
|
- |
|
Calhoun Christopher J |
Chief Executive Officer |
|
2006-05-08 |
4 |
OE |
$0.15 |
$420 |
D/D |
2,800 |
52,800 |
|
- |
|
Calhoun Christopher J |
Chief Executive Officer |
|
2006-05-05 |
4 |
S |
$8.06 |
$1,128 |
D/D |
(140) |
50,000 |
|
- |
|
Calhoun Christopher J |
Chief Executive Officer |
|
2006-05-05 |
4 |
OE |
$0.15 |
$21 |
D/D |
140 |
50,140 |
|
- |
|
Calhoun Christopher J |
Chief Executive Officer |
|
2006-05-04 |
4 |
AS |
$8.06 |
$27,404 |
D/D |
(3,400) |
50,000 |
|
- |
|
Calhoun Christopher J |
Chief Executive Officer |
|
2006-05-04 |
4 |
OE |
$0.15 |
$510 |
D/D |
3,400 |
53,400 |
|
- |
|
Calhoun Christopher J |
Chief Executive Officer |
|
2006-05-02 |
4 |
S |
$8.06 |
$1,612 |
D/D |
(200) |
50,000 |
|
- |
|
Calhoun Christopher J |
Chief Executive Officer |
|
2006-05-02 |
4 |
OE |
$0.15 |
$30 |
D/D |
200 |
50,200 |
|
- |
|
Calhoun Christopher J |
Chief Executive Officer |
|
2006-05-01 |
4 |
AS |
$8.06 |
$64,480 |
D/D |
(8,000) |
50,000 |
|
- |
|
Calhoun Christopher J |
Chief Executive Officer |
|
2006-05-01 |
4 |
OE |
$0.15 |
$1,200 |
D/D |
8,000 |
58,000 |
|
- |
|
Calhoun Christopher J |
Chief Executive Officer |
|
2006-03-14 |
4 |
AS |
$7.50 |
$3,600 |
D/D |
(480) |
50,000 |
|
- |
|
Calhoun Christopher J |
Chief Executive Officer |
|
2006-03-14 |
4 |
OE |
$0.15 |
$72 |
D/D |
480 |
50,480 |
|
- |
|
Calhoun Christopher J |
Chief Executive Officer |
|
2006-03-02 |
4 |
AS |
$7.55 |
$1,510 |
D/D |
(200) |
50,000 |
|
- |
|
Calhoun Christopher J |
Chief Executive Officer |
|
2006-03-02 |
4 |
OE |
$0.15 |
$30 |
D/D |
200 |
50,200 |
|
- |
|
Calhoun Christopher J |
Chief Executive Officer |
|
2006-02-27 |
4/A |
OE |
$0.15 |
$75 |
D/D |
500 |
50,500 |
|
- |
|
Calhoun Christopher J |
Chief Executive Officer |
|
2006-02-27 |
4 |
S |
$7.50 |
$3,750 |
D/D |
(500) |
50,000 |
|
- |
|
Calhoun Christopher J |
Chief Executive Officer |
|
2006-02-27 |
4 |
OE |
$0.15 |
$75 |
D/D |
500 |
50,000 |
|
- |
|
Calhoun Christopher J |
Chief Executive Officer |
|
2006-02-24 |
4/A |
OE |
$0.15 |
$75 |
D/D |
500 |
50,500 |
|
- |
|
340 Records found
|
|
Page 12 of 14 |
|
|